Korro Bio (KRRO) announced the appointment of Loic Vincent, Ph.D., as the Company’s Chief Scientific Officer. Prior to joining Korro, Dr.

Dr. Vincent, who previously served as Chief Scientific Officer at Affini-T Therapeutics and held leadership roles at Takeda and Sanofi, remarked on the potential of Korro’s RNA-editing ...